Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRF and Isotretinoin in Moderate to Severe Acne Vulgaris
NCT06378983Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Sep 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of isotretinoin in acne vulgaris, sponsored by Sun Yat-sen Memorial Hospital. Started Sep 2022; status: recruiting.
02
Drugs
isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT06378983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06378983.